Data and Code for: A Dose of Managed Care?
Principal Investigator(s): View help for Principal Investigator(s) Christopher Ody, Analysis Group; Amanda Starc, Northwestern University; David Dranove, Northwestern University
Version: View help for Version V1
Project Citation:
Ody, Christopher, Starc, Amanda, and Dranove, David. Data and Code for: A Dose of Managed Care? Nashville, TN: American Economic Association [publisher], 2021. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2021-05-25. https://doi.org/10.3886/E115927V1
Project Description
Summary:
View help for Summary
We study the effect of privatizing Medicaid drug benefits on drug prices and utilization. Drug spending would decrease by 21.3 percent if private insurers administered all drug benefits. One-third of the decrease is driven by private insurers’ ability to negotiate prices with pharmacies. The remaining two-thirds is driven by the greater use of lower cost drugs, such as generics, and is only realized in states that give private insurers the flexibility to design drug benefits. Privatization does not reduce prescriptions per enrollee and spending cuts are smaller for drugs that lower medical spending.
Scope of Project
JEL Classification:
View help for JEL Classification
I11 Analysis of Health Care Markets
I13 Health Insurance, Public and Private
L10 Market Structure, Firm Strategy, and Market Performance: General
I11 Analysis of Health Care Markets
I13 Health Insurance, Public and Private
L10 Market Structure, Firm Strategy, and Market Performance: General
Related Publications
Published Versions
Report a Problem
Found a serious problem with the data, such as disclosure risk or copyrighted content? Let us know.
This material is distributed exactly as it arrived from the data depositor. ICPSR has not checked or processed this material. Users should consult the investigator(s) if further information is desired.